Qrem

1 known investors

Qrem develops a lab-in-a-box medical device that produces autologous cytokine-rich serum (SARC) from a patient's own blood for regenerative medicine treatment of soft and hard tissue damage. The device enables healthcare practitioners to prepare and administer the therapy directly in their clinic without specialized infrastructure.